Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer

Title
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
Authors
Keywords
-
Journal
NEW ENGLAND JOURNAL OF MEDICINE
Volume 375, Issue 18, Pages 1738-1748
Publisher
New England Journal of Medicine (NEJM/MMS)
Online
2016-10-08
DOI
10.1056/nejmoa1609709

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started